Teleflex's ArrowEvolution
This article was originally published in The Gray Sheet
Executive Summary
Anti-microbial, peripherally inserted central catheter will debut in the U.S. in the fourth quarter following receipt of 510(k) clearance, announced Sept. 7. The ArrowEvolution PICC with Chlorag+ard technology has a chlorhexidine-based solution bonded to the catheter's surface. The firm says the anti-microbial coating will help health care providers protect against central line-associated bloodstream infections. The product complements Teleflex's currently available Arrowg+ard Blue Plus acute central venous catheter with chlorhexidine